Leptin and its long form receptor, Ob-Rb, in the hypothalamus play a key function in regulating food intake and body weight. We demonstrate here that apolipoprotein D (Apo D), a lipocalin that is heavily expressed in brain, interacts specifically with the cytoplasmic portion of Ob-Rb but not the short form receptor, Ob-Ra. This finding is detected in yeast two-hybrid systems as well as in protein precipitation experiments in vitro and in vivo. Apo D and Ob-Rb are coexpressed in neurons of the hypothalamic arcuate and paraventricular nuclei that are known to be involved in eating and body weight regulation. Moreover, hypothalamic level of Apo D mRNA is stimulated by dietary fat. It is also significantly elevated in rats and inbred mice that become obese on a highfat diet, compared with their lean controls, and is strongly, positively correlated with body fat mass and circulating leptin levels. This positive association with body fat, however, is lost in obese ob-/ob-and db-/db-mice, which exhibit markedly reduced levels of hypothalamic Apo D mRNA compared with that of wild-type mice. These results suggest that Apo D in the hypothalamus is involved in the leptin/Ob-Rb signal transduction pathway that controls body fat accumulation on a high-fat diet. polipoprotein D (Apo D) was originally purified from blood as a minor apoprotein component of the high-density lipoprotein particles and was thus designated as apolipoprotein (1). However, Apo D does not show sequence similarity to other apolipoproteins (2). Instead, it is a member of the lipocalin family of proteins that are characterized by a conserved eight-stranded, beta-barrel tertiary structure and function in the binding and transporting of small hydrophobic ligands (3). The physiological function of Apo D, as well as the identity of its putative ligand, remains to be characterized. It has been proposed that Apo D is a transporter for an unknown ligand that is structurally similar to heme-related molecules, such as biliverdin and porphyrins (4). In addition, Apo D might bind and transport other ligands, including arachidonic acid, cholesterol, and steroid hormones such as progesterone and pregnenolone (2, 5) . This ability of Apo D to associate with a variety of ligands suggests that it might have multiple, tissue-specific functions. For example, Apo D binds progesterone in breast A cyst fluid (6), and it also binds and transports an axilliary odorant when it is secreted from apocrine glands (7).
polipoprotein D (Apo D) was originally purified from blood as a minor apoprotein component of the high-density lipoprotein particles and was thus designated as apolipoprotein (1) . However, Apo D does not show sequence similarity to other apolipoproteins (2) . Instead, it is a member of the lipocalin family of proteins that are characterized by a conserved eight-stranded, beta-barrel tertiary structure and function in the binding and transporting of small hydrophobic ligands (3) . The physiological function of Apo D, as well as the identity of its putative ligand, remains to be characterized. It has been proposed that Apo D is a transporter for an unknown ligand that is structurally similar to heme-related molecules, such as biliverdin and porphyrins (4) . In addition, Apo D might bind and transport other ligands, including arachidonic acid, cholesterol, and steroid hormones such as progesterone and pregnenolone (2, 5) . This ability of Apo D to associate with a variety of ligands suggests that it might have multiple, tissue-specific functions. For example, Apo D binds progesterone in breast A cyst fluid (6) , and it also binds and transports an axilliary odorant when it is secreted from apocrine glands (7) .
Although it is present in a wide range of peripheral tissues in primates and rabbits (8) , Apo D is highly concentrated in brain and is almost undetectable in most peripheral tissues in rodents (9) . It is reported that, in brain, Apo D is expressed in the parenchyma, as well as in the subarachnoid space and pia matter, and it is synthesized in a number of cell types, including neurons, neuroglial cells, astrocytes, fibroblasts, and perivascular cells (10, 11) . There is evidence that excitotoxic injury significantly stimulates Apo D expression in hippocampal pyramidal neurons (12, 13) . Further, Apo D expression is elevated in these neurons and in cerebellar Purkinje cells that are undergoing degeneration (14, 15) . These observations suggest a role for Apo D in neuronal degeneration.
However, the specific mechanisms that control Apo D expression in neurons are unknown. It has been reported that glucocorticoids, progesterone, and testosterone stimulate the expression and secretion of Apo D in cultured cells, whereas estrogens inhibit Apo D (16) (17) (18) . Because these steroids modulate food intake, nutrient metabolism, and body weight (19) (20) (21) (22) , their ability to affect Apo D expression may suggest a function for this protein in energy homeostasis and body weight control. This notion is further supported by human genetic studies that have linked a polymorphism of Apo D to obesity and hyperinsulinemia in a British Caucasoid population (23) . A polymorphism has also been linked to noninsulin-dependent diabetes mellitus in South Indians and Nauruans (24) .
Dietary fat contributes to the development of obesity in animals and humans (25) . In rodents, it has been demonstrated that the concentration of fat in the diet, but not protein or carbohydrate, is strongly, positively correlated with the amount of body fat mass and that free access to a high-fat diet causes obesity and hyperinsulinemia (26) (27) (28) . These effects of dietary fat may be mediated, at least in part, by changes in the expression of genes in the brain that are involved in energy balance (29) (30) (31) . Dietary fat also affects circulating levels of leptin, a hormone predominantly secreted from adipose tissues (32, 33) . Leptin controls energy balance through its long form receptor (Ob-Rb) on neurons in the hypothalamus (34) . A mutation of this hormone or its receptor causes severe obesity in rodents and humans (35) (36) (37) (38) . Moreover, leptin levels rise with dietary fat and are strongly, positively correlated with body fat mass (39) . It promotes fat oxidation, satiety, and facilitates the distribution of lipids throughout the body (40, 41) . Leptin and its receptor are believed to function through a JAK/STAT signal transduction pathway (42) and might interact with other signaling pathways involved in eating and body weight regulation (43, 44) .
In this study, we sought to identify genes that are functionally linked to both dietary fat and Ob-Rb in the hypothalamus. We found strong evidence indicating an interaction between Apo D and the cytoplasmic portion of Ob-Rb in vitro and in vivo. We observed the coexistence of Apo D and Ob-R in hypothalamic neurons, as well as a positive correlation between hypothalamic Apo D mRNA level, body fat mass, and leptin. Our results suggest that Apo D in the hypothalamus may constitute a component of the leptin/Ob-Rb signal transduction pathway through which leptin modulates energy homeostasis.
MATERIALS AND METHODS

Animals, tissues, and physiological studies
Male Sprague-Dawley rats and mouse strains, AKR/J, SWR/J, C57BL/6j, and C57BL/6j ob-/ob-(Charles River Laboratories, Wilmington, Mass.) were maintained on either a low-fat diet (10% fat, 25% protein, 65% carbohydrate, 3.75 Kcals/gram), moderate-fat diet (30% fat, 25% protein, 45% carbohydrate, 3.98 Kcals/gram), or high-fat diet (60% fat, 25% protein, 15% carbohydrate, 5.10 Kcals/gram). Procedures for diet preparation, measurement of food intake and body weight, and dissection of body fat pads (inguinal, epididymal, interperitoneal, and mesenteric) and medial hypothalamus have been described previously (31) . Blood was collected at killing for measurement of leptin by RIA (Linco Research, St. Charles, Mo.). All other rat tissues were obtained from Harlan Bioproducts (Indianapolis, Ind.). The data for body weight, body fat, and serum leptin levels, as well as for Apo D mRNA levels in hypothalamus obtained by quantitative RT-PCR (see below), were analyzed statistically by using an unpaired Student's t-test.
Identification and cloning of Apo D
Medial hypothalamus from 10 rats on a high-fat diet or low-fat diet were pooled for the purification of mRNA, which was then used for RDA as previously described (45) . The cDNA fragment of rat Ob-Rbc (C terminal), obtained by RT-PCR with primers 5'TCACACCAGAGAATGAAAAAG3' and 5'CACAGTTAAGTCACACATCTTA3', was used to screen a rat brain two-hybrid library (Clontech, Palo Alto, Calif.) according to the provided methods. By RT-PCR, the cDNA fragment of rat Apo D was obtained with primers 5'GAATTCATGGCGACCATGCTGTTGC3' and 5' GTCGACTTACAGGAAGTCCGGGCAG3'. These cDNA fragments were cloned into plasmid pGEM-Teasy (Promega, Madison, Wis.).
Protein expression and purification
The cDNA fragment of rat Ob-Rac obtained by RT-PCR with primers 5'TCACACCAGAGAATGAAAAAG3' and 5'AAGAGTGTCCGCTCTCTTTTG3' was cloned into pGEM-Teasy. Ob-Rac and Ob-Rbc were subcloned into pET-32a(+) (Novagen, Milwaukee, Wis.) for protein expression. To generate Ob-Rbt, pET-32a(+)-Ob-Rbc was digested by Kpn I, followed by polishing of the sticky ends to flush ends and religation. The bacteria expressing Trx•Ob-Rbc and Trx•Ob-Rbt were solubilized in buffer TUNN (10 mM Tris, 8 M urea, 100 mM NaH 2 PO 4 , 0.5% NP-40) supplemented with 5 mM imidazole, pH 7.9. The proteins were purified with a Ni-NTA Superflow column (Qiagen, Valencia, Calif.) by washing sequentially with TUNN plus 20 mM imidazole, pH 7.9, and TUNN plus 20 mM imidazole, pH 6.3. The proteins were eluted with TUNN plus 20 mM imidazole, pH 5. 
Protein precipitation
The proteins were combined with either 50 µl of 50% Ni-NTA Superflow agarose resin or 50 µl of 50% glutathione Sepharose 4B in 1 ml of PBS, pH 7.4, plus 1% NP-40, 1 mM EGTA and phenylmethylsulfonyl fluoride, and 1 µg/ml each of leupeptin and pepstatin A. The mixture was shaken at 37 o C for 1 h, pelleted at 400 g in a microcentrifuge, and washed four times with 1 ml of PBS. A mouse monoclonal antibody against His•Tag was purchased from Oncogene Research Products (Cambridge, Mass.). A goat polyclonal antibody against GST was purchased from Amersham Pharmacia Biotech. Alkaline phosphatase conjugate secondary antibodies were obtained from Sigma (St. Louis, Mo.).
For in vivo immuno-precipitation, protein extract was made by homogenizing 100 rat hypothalami in 10 ml of PBS, pH 7.4, plus 1 mM EGTA, and 1 µg/ml each of leupeptin and pepstatin A, followed by centrifugation at 24,000 g at 4 o C for 1 h. This extract (7.8 mg/ml) was divided into two parts, which were combined with 100 µg goat anti-Ob-Rb antibody (Santa Cruz Biotechnology, Santa Cruz, Calif.) or with 100 µg normal goat IgG (Oncogene Research Products) plus 100 µl 50% protein G agarose beads (Upstate Biotechnology, Lake Placid, N.Y.), and shaken at . PCR products were separated in a 5% polyacrylamide gel, stained by ethidium bromide, and digitally quantified by an imaging densitometer GS-700 (Bio-Rad, Hercules, Calif.). The results were averaged from four independent experiments.
In situ hybridization and immunohistochemistry
Antisense and sense riboprobes were transcribed in vitro from linearized DNA of plasmid pGEMTeasy containing the cDNA of Apo D or Ob-Rb, by using SP6 or T7 RNA polymerase, in the presence of biotin-UTP (NEN TM Life Science Products, Boston, Mass.). The probe for Apo D corresponds to 63-570 bp of the cDNA, whereas the probe for Ob-Rb corresponds to 2985-3486 bp in the cytoplasmic portion. In situ hybridization was performed on frozen brain sections from adult male Sprague-Dawley rats as described (31) , and the signal was enhanced with tyramide (NEN TM Life Science Products) and detected by NBT/BCIP (Boehringer Mannheim). In the immunohistochemical studies, a monoclonal anti-human Apo D antibody (Heart Institute Research Corp.) and a polyclonal (goat) anti-Ob-R antibody (Santa Cruz) were used to detect Apo D and Ob-R protein in rat brain. Fluorescein-and cyanine-3-conjugated secondary antibodies (Jackson ImmunoResearch laboratories, West Grove, Pa.) were used in the double-labeling experiments.
RESULTS
Identification of Apo D
To clone genes that regulate food ingestion and body fat accrual, we used representational difference analysis (RDA) (45) to identify genes that exhibit increased expression in the hypothalamus of rat maintained on a high-fat diet, which is known to enhance hypothalamic expression of peptides involved in energy balance (29) (30) (31) . A large number of candidate clones was obtained from this analysis. We then investigated whether any of these clones encode proteins that interact with the long form receptor of leptin, which controls food intake and body weight and is also stimulated by a high-fat diet (32, 33) . This research was performed by using the yeast twohybrid technique (46) to screen a rat brain cDNA library for proteins that interact with the cytoplasmic domain of Ob-Rb, and by then searching the resultant clones for DNA sequences that are identical to those generated by RDA.
In the RDA experiment, the cDNA fragments were prepared from two groups of adult, male Sprague-Dawley rats (n=10/group) maintained for 3 wk on one of two diets, either a low-fat (10% fat, 3.75 Kcals/g) or high-fat (60%, 5.10 Kcals/g) diet. The cDNA fragments made from the medial hypothalamus of the low-fat diet rats were subtracted from those of the high-fat diet rats, and the resultant cDNA fragments were amplified by PCR. After three rounds of subtraction and amplification, distinct DNA bands were obtained in agarose gel (Fig. 1) . The subsequent cloning and sequencing of these DNA fragments (53 clones) revealed a clone containing a 0.5 Kb cDNA fragment of Apo D.
In a GAL4 yeast two-hybrid system, the cytoplasmic domain immediately following the transmembrane region of rat Ob-Rb, hereafter referred as Ob-Rbc (for C terminal), was cloned by RT-PCR and used as the bait to screen a rat brain cDNA library. Through an initial screening of approximately 2 × 10 6 yeast colonies, 436 clones were obtained. A second screening of these clones by an X-GAL filter assay yielded 57 clones, all of which were sequenced. Sequence comparison revealed a clone from the cDNA library that overlapped the 0.5 Kb cDNA fragment of Apo D obtained from the RDA experiment. This clone contained a 0.9 Kb N-terminal truncated cDNA fragment of Apo D.
Dietary fat stimulates Apo D expression in hypothalamus
The result from the above RDA experiment indicates that dietary fat stimulates the hypothalamic mRNA level of Apo D. To confirm this finding, we measured Apo D mRNA in the medial hypothalamus by quantitative RT-PCR in an additional set of rats (n=5-6/group) maintained for 3 wk on either a low-fat (10%), moderate-fat (30%), or high-fat (60%) diet. The results, presented in Table 1 , demonstrate that the relative (to actin) Apo D mRNA level increases significantly as dietary fat rises from 10% to 30% (+19%, p<0.03) and even further in rats on a 60% fat diet (+25%, p<0.001). This increase in dietary fat concentration and Apo D mRNA is accompanied by a significant rise in circulating levels of leptin (Table 1) . Body fat pad weights (retroperitoneal, inquinal, mesenteric and epididymal), as well as body weight and total daily intake, are also elevated in the high-fat diet rats (Table 1) .
Apo D interacts with Ob-Rb
The identification of Apo D by the yeast two-hybrid technique indicates that Apo D interacts with Ob-Rbc. It is known that Apo D is abundantly expressed in the brain of rodents (9, 10, 47) . However, only one Apo D clone was obtained from the rat brain cDNA library, which suggests that the binding between Apo D and Ob-Rbc is weak. To confirm this theory, we performed β-galactosidase activity assays in the GAL4 yeast two-hybrid system to measure the strength of this interaction. Although the negative control generated 0.2 unit of β-galactosidase activity, 4 units of activity were found in the interaction between Apo D and Ob-Rbc. This finding contrasts with 108 units of β-galactosidase activity in a positive control interaction between p53 and T antigen. This low β-galactosidase activity confirms that the interaction between Ob-Rbc and Apo D is weak and explains the low yield of Apo D clones in the library screening.
To further confirm the binding between Apo D and Ob-Rbc, we tested their interaction in a different LexA yeast two-hybrid system (48) . In these experiments, only the yeast harboring Apo D and Ob-Rbc fusion proteins grew, and the resultant colonies turned blue within 3 d on the test medium, demonstrating that Apo D interacts with Ob-Rbc (Fig. 2, right) . The specificity of this interaction is summarized in Table 2 . It shows that, although Apo D interacts with Ob-Rbc (row 6), it does not interact with the DNA-binding domain or lamin C (rows 3 and 4), a structural protein found inside the nucleus. In addition, no interaction is seen between Ob-Rbc and the activation domain or T antigen (rows 2 and 5). Thus, this experiment indicates that Apo D interacts specifically with Ob-Rbc in the yeast two-hybrid system.
We additionally confirmed this interaction with purified proteins by protein-to-protein interaction experiments in vitro. The intact cDNA of rat Apo D was obtained by RT-PCR, expressed in bacteria as a GST-fusion protein, and purified. Ob-Rbc was expressed in bacteria as a thioredoxin (Trx)-fusion protein. Because the majority of Trx•Ob-Rbc forms inclusion bodies when highly expressed in bacteria, Trx•Ob-Rbc was solubilized by 8M urea, purified, and renatured in a phosphate buffer. In these protein-to-protein interaction experiments, 20 µg of Trx•Ob-Rbc was found to coprecipitate with 1 µg of GST•Apo D, but not with 1 µg of GST when GST and GST•Apo D were precipitated with glutathione agarose beads (Fig. 3A, lanes 1 and 2) . Reciprocally, 1 µg of GST•Apo D coprecipitated with 20 µg of Trx•Ob-Rbc, but not with 20 µg of Trx when Trx and Trx•Ob-Rbc were precipitated with Ni-NTA Superflow TM resin (Fig. 3A, lanes  3 and 4) . In these experiments, we found that a large quantity of Trx•Ob-Rbc (20 µg) is required for the interaction to be detected. This finding may indicate that only a small fraction of Trx•ObRbc is correctly renatured and bound with Apo D. To substantiate that native Trx•Ob-Rbc interacts with Apo D, we concentrated the soluble Trx•Ob-Rbc in the bacterial extract by affinity chromatography purification and used it in the protein binding experiment. The same results were obtained by using this procedure (data not shown). Thus, these findings independently confirm that Apo D binds with the cytoplasmic portion of Ob-Rb.
Apo D does not interact with Ob-Ra
Ob-Rb is believed to play a key role in reducing body fat accumulation because its mutation in C57BL/k s db-/db-mice-in which it is changed into the short form, Ob-Ra-results in a massive increase in adiposity and obesity (35, 37) . Ob-Ra, which also exists in nature, may have a function in mediating the entry of leptin into the brain (49, 50) . It is therefore of interest to test whether the interaction between Apo D and Ob-Rb is specific to this receptor subtype or whether it also occurs with Ob-Ra.
To examine the interaction between Apo D and Ob-Ra with purified proteins in vitro, we cloned the cDNA encoding the cytoplasmic domain of rat Ob-Ra (Ob-Rac) by RT-PCR, expressed it as a Trx-fusion protein (Trx•Ob-Rac) in bacteria, and purified it. In this protein-to-protein interaction experiment, 1 µg of GST•Apo D did not coprecipitate with 20 µg of Trx•Ob-Rac when Trx•ObRac was precipitated by Ni-NTA SuperflowTM resin (Fig. 3A, lane 5) . This finding was in contrast to the interaction between GST•Apo D and Trx•Ob-Rbc, which was used as a positive control (Fig. 3A, lane 6) . Further, Apo D does not interact with Ob-Rac in LexA yeast two-hybrid system ( Fig. 2 and Table 2 , row 7). Therefore, through independent approaches, we have demonstrated that Apo D fails to interact with Ob-Ra. Unexpectedly, we found that Ob-Rac binds with T antigen in the yeast ( Table 2 , row 8). Because T antigen shares a number of motifs with eukaryotic proteins, this finding may suggest that Ob-Ra binds with other unidentified protein(s).
The above experiments indicate that the amino acid sequence responsible for the interaction with Apo D is present in Ob-Rbc but not Ob-Rac. To confirm this presence, we generated a truncated Ob-Rbc (Ob-Rbt) by removing a stretch of sequence at the N terminus of Ob-Rbc (Fig. 3B) . 3A, lanes 9 and 10) . These experiments indicate that Ob-Rbt is sufficient for the interaction between Apo D and Ob-Rbc. However, the amino acids or motifs on both Apo D and Ob-Rbt involved in this interaction remain to be determined.
To provide evidence for in vivo interaction between Apo D and Ob-R, we conducted an immunoprecipitation experiment with proteins extracted from pooled rat hypothalamus (Fig. 4) . Ob-Rb and its associated proteins were precipitated by a polyclonal goat anti-Ob-R antibody and protein G agarose beads. After extensive washing, a single band of ~30 kilo-Daltons representing the glycosylated Apo D was detected (Fig. 4, lane 1) by using a monoclonal anti-human Apo D antibody (51) that specifically binds to Apo D (52, 53) . In contrast, a mock precipitation, in which the goat anti-Ob-R antibody was replaced by normal goat IgG, generated no signal (Fig. 4, lane 2) . This finding provides evidence that hypothalamic Apo D interacts with Ob-R in vivo.
Apo D and Ob-Rb are coexpressed in hypothalamic neurons
If Apo D and Ob-Rb interact in vivo, one would expect anatomical overlap in their expression patterns. To demonstrate this theory, we first examined their relative mRNA levels in various tissues in rat by quantitative RT-PCR. As shown in Figure 5 , the most abundant Apo D expression is detected in brain, with the highest level in hypothalamus. Whereas moderate levels of Apo D mRNA were found in pituitary and low levels in lung and testis, the remaining tissues showed little Apo D expression, consistent with published evidence (9, 10, 47) . The expression of Ob-Rb overlaps that of Apo D, notably in the hypothalamus and brain, and with low-to-moderate levels in pituitary, testis, and lung. In contrast, Ob-Ra mRNA, while at very low levels in tissues expressing Apo D, is predominantly seen in intestine, liver, spleen, and ovary (Fig. 5 ).
We further demonstrated by in situ hybridization that Apo D mRNA is present in hypothalamic nuclei known to express Ob-Rb. With a biotin-labeled, anti-sense RNA probe, Apo D-positive signals can be seen in the paraventricular and arcuate nuclei of rats on a high-fat diet (Fig. 6) , with lower levels detected in the ventromedial nucleus (not shown). These positive signals, apparently in neurons, are specific to Apo D mRNA because the control sense RNA probe generates no signal, as shown for the paraventricular nucleus (Fig. 6, lower panel) . Additionally, Apo D-positive signals were also observed in unidentified cells scattered throughout the parenchyma of the thalamus, hippocampus, cortex, and choroid plexus, as well as the pituitary (not shown).
By using a monoclonal anti-human Apo D antibody (51), we also observed the existence of Apo D protein in neurons of hypothalamic nuclei in immunohistochemical experiments. As shown in Figure 7 (top panel), the immunoreactivity for Apo D is evident in the cytoplasm of neurons, both parvocellular and magnocellular, of the paraventricular nucleus and also in small neurons of the arcuate nucleus. This immunoreactivity is specific to Apo D protein, because no signal was generated when the above antibody was pre-absorbed by purified human Apo D (not shown). Ob-R immunoreactivity is also present in neurons of the paraventricular and arcuate nuclei, as revealed by using a polyclonal anti-Ob-R antibody (Fig. 7, middle panel) . In this double-labeling experiment, we found that the proteins of both Apo D and Ob-R are clearly colocalized in the same neurons of these hypothalamic nuclei ( Figure 7 , lower panel). This coexistence is also observed in other areas, including the hypothalamic supraoptic nucleus, cortex, and choroid plexus (not shown).
Hypothalamic Apo D mRNA levels correlate positively with body fat and circulating leptin
To explore a possible relationship of Apo D to body fat mass, we used quantitative RT-PCR to determine the relative Apo D mRNA levels in the medial hypothalamus of rats exhibiting differential body fat accrual on a high-fat diet. In this experiment, Sprague-Dawley rats were fed ad libitum on a high-fat diet for 3 wk. Based on the amount of body fat accumulated (measured in four dissected depots) over this period, these subjects were then divided into two subgroups (31), referred to as 'lean' (n=7) with 15-21 g body fat or 'obese'" (n=8) with 26-34 g body fat (Table  3 ). Whereas both groups were similar in their total daily intake, the obese rats with approximately 50% greater body fat had significantly higher Apo D mRNA levels in the medial hypothalamus. They also had considerably higher levels of circulating leptin (Table 3) . Across the whole group, Apo D mRNA was found to be strongly, positively correlated with total body fat (r=+0.87, p<0.01), body weight (r=+0.82, p<0.01) and the level of leptin (r=+0.76, p<0.01), which in turn was positively related to adiposity (r=+0.87, p<0.01).
Similar results were obtained in inbred mouse strains with a differential propensity toward obesity. Two strains, SWR/J and AKR/J (54), were placed on a high-fat diet for 3 wk (n=6/group), and their relative medial hypothalamic mRNA levels of Apo D were determined by quantitative RT-PCR. The obesity-prone AKR/J mice, with 60% greater body fat mass but equal total intake, had significantly higher levels of Apo D mRNA compared with the lean SWR/J mice (Table 3) . Moreover, positive correlations in both strains, ranging from r=+0.66 to r=+0.76 (p<0.05), were observed between medial hypothalamic Apo D mRNA and body fat.
Apo D mRNA levels are reduced in medial hypothalamus of ob-/ob-and db-/db-mice
The above observation suggests that hypothalamic Apo D expression is closely related to the degree of adiposity. In the present experiment, we investigated whether Apo D remains positively associated with body fat mass in mouse strains that are remarkably obese because of a mutated leptin or Ob-Rb gene.
We first examined Apo D expression in C57BL/3j db-/db-mice by using quantitative RT-PCR. Because of their mutational loss of the cytoplasmic portion of Ob-Rb (55) (Table 3) . These findings, indicating that a functional leptin/Ob-Rb signaling process is required for the upregulation of Apo D expression, support a possible role for hypothalamic Apo D in the control of body fat accrual.
DISCUSSION
In this study, we demonstrated that Apo D interacts specifically with the cytoplasmic portion of Ob-Rb. This interaction is detected in a GAL4 two-hybrid system in yeast and is shown additionally in a LexA yeast two-hybrid system. With purified proteins, it is further demonstrated reciprocally in protein precipitation experiments in vitro. However, we find that Apo D, both in yeast and with purified proteins in vitro, does not interact with Ob-Ra, which may mediate the entry of leptin into the brain (49, 50) . Further, by using a truncated Ob-Rbc, we demonstrate that Ob-Ra does not possess the amino acids required for interaction with Apo D. These amino acids are within a stretch of 229 amino acids located at the C-terminus of Ob-Rb. This region contains a protein-binding motif for interacting with the SH2 domain of STAT proteins (35, 37) . Apo D most likely does not interact with Ob-Rb via this motif because sequence similarity is not found between Apo D and STAT proteins, nor is there an obvious SH2 homologue in Apo D (2, 57). Thus, it is possible that Ob-Rb, which is believed to function through the JAK/STAT pathway (35, 37) , also interacts with the non-STAT protein, Apo D, through unidentified motifs in the cytoplasmic domain of Ob-Rb.
In support of their interaction in vivo, we demonstrate by immuno-precipitation experiments that Apo D binds with Ob-R in protein extracts made from rat hypothalamus. Further, Apo D in hypothalamus, rather than derived from blood, appears to be synthesized in neurons, perhaps in addition to other cell types. This finding is demonstrated by our in situ hybridization and immunohistochemistry experiments in which Apo D mRNA and protein are detected in neurons of the paraventricular and arcuate nuclei. These hypothalamic nuclei are known to express Ob-Rb (58-60) and to be involved in the regulation of food intake and body weight (61) . Our observation that Apo D exists in the cytoplasm of these neurons is consistent with electron microscopy studies that place Apo D in the cytoplasm of hippocampal and cerebellar neurons (12, 62) . This finding indicates that Apo D is physically accessible for its interaction with the cytoplasmic domain of ObRb. In fact, by using double-labeling immunohistochemistry, we demonstrate that Apo D and ObRb actually coexist within the same neurons of the paraventricular and arcuate nuclei (Fig. 7) . These experiments strongly indicate that Apo D interacts with Ob-Rb in vivo in hypothalamic neurons involved in energy balance.
This interaction between Apo D and Ob-Rb may occur in other brain areas as well. For example, it is reported that Apo D is expressed in Purkinje neurons of the cerebellum (62), where Ob-Rb mRNA is also expressed (58) . In our present studies, we found that an anti-Ob-R antibody can additionally precipitate Apo D from protein extracts made from cerebellum. Further, in doublelabeling immunohistochemistry experiments, we observed the coexistence of Apo D and Ob-R in the cortex and choroid plexus. It is thus possible that Apo D and Ob-Rb may interact in other systems as well, with the functional significance yet to be determined.
The involvement of Apo D in the regulation of food intake and body fat accrual is also suggested by our physiological studies. We found that fat intake significantly stimulates Apo D expression in the hypothalamus. This elevation is concomitant and strongly correlated with circulating levels of leptin, which also rise with dietary fat. Moreover, a strong, positive correlation is detected between hypothalamic Apo D mRNA level and body fat pad weights. This relationship is observed in outbred Sprague-Dawley rats. It is also evident in inbred mouse strains that show variable propensity toward obesity on a high-fat diet. However, ob-/ob-and db-/db-mice fail to exhibit this positive association between Apo D and adiposity. In fact, they have considerably reduced levels of hypothalamic Apo D mRNA compared with their lean wild-type littermates. These experiments indicate that the leptin/Ob-Rb signaling pathway modulates Apo D expression in hypothalamic neurons and possibly mediates the stimulation of Apo D expression observed in relation to fat intake and body fat. In ob-/ob-and db-/db-mice with a mutant leptin or Ob-Rb gene, the reduced expression of hypothalamic Apo D, resulting in a deficiency of Apo D protein, may contribute to the development of their obesity, particularly on a high-fat diet.
Although designated an 'apolipoprotein', Apo D actually belongs to lipocalins (2, 57), a family of proteins that bind and transport small hydrophobic ligands (3). However, the specific ligand to which Apo D binds has not been unequivocally identified. Numerous reports suggest that it may bind to a variety of small molecules (2, 5) . The fact that Apo D binds with progesterone in breast cyst fluid (6) and with an axillary odorant in apocrine glands (7) suggests that the ligand may be specific to the tissue or cell type where Apo D is expressed. We thus speculate that Apo D may have a specific ligand in hypothalamic neurons where it exerts signaling functions similar to that of other apolipoproteins (63) . This putative ligand may be produced as a consequence of the leptin stimulation of Ob-Rb. In fact, previous work has suggested the existence of a ligand generated following the activation of Ob-Rb (64) . This Apo D specific ligand may be either a small molecule that functions as a paracrine signal within particular hypothalamic nuclei or a hormone that enters the circulation, possibly via the pituitary where both Apo D and Ob-Rb are expressed in moderate levels (Fig. 5) . Pregnenolone may be one such candidate that deserves further investigation as a specific ligand that binds Apo D in the hypothalamus and participates in body weight regulation. This steroid is present in the brain and associates with Apo D with high affinity (65, 66) . Further, its production is modulated by leptin (67) , and high plasma levels of pregnenolone are associated with hyperphagia in rats (68) and obesity in humans (69).
Our work strongly indicates that Apo D constitutes a component of the leptin/Ob-Rb signaling pathway. By serving as a carrier for a leptin-stimulated ligand, Apo D itself may play a contributing role in the regulation of body fat accrual. This proposed function of hypothalamic Apo D is consistent with the finding that a Taq I Apo D polymorphism is linked to obesity and hyperinsulinemia (23) . An Apo D polymorphism is also associated with noninsulin dependent diabetes mellitus (24), a condition commonly associated with obesity in animals and humans (70) . The transformants were grown in synthetic dextrose medium lacking histidine, tryptophan and uracil at 30 o C for 3 days. The yeast was then streaked onto synthetic galactose/raffinose plates containing X-Gal but lacking either histidine, tryptophan and uracil (control medium), or leucine, histidine, tryptophan and uracil (test medium). The plates were incubated at 30 o C for 3 days. Colonies began to appear on day 2 (plus signs) and turned to blue or dark blue on day 3, indicating the interaction of the corresponding proteins in yeast. used to obtain small cDNA fragments representing up-regulated genes expressed in hypothalamus of rats maintained on a high-fat diet. cDNA fragments (40 µg) made from hypothalamus of rats on a low-fat (10%) diet was subtracted from cDNA fragments (0.1 µg) from high-fat (60%) diet rats (n=10/group), followed by PCR. After three successive subtractions and PCR, the products (1 µg, lanes 1, 2, and 3) were resolved in 1% agarose gel. The DNA bands, each consisting of a mixture of cDNA fragments, were excised from the gel and cloned randomly. The position of Apo D is indicated (arrowhead) based on the length of the cDNA fragment. 4 . Protein-to-protein interaction in vivo. Ob-R and its associated proteins were precipitated by a goat anti-Ob-R antibody and protein G agarose beads (Lane 1) from protein extracts made from pooled rat hypothalamus at 4 o C overnight. After being washed four times, proteins were separated in a 10% polyacrylamide gel and assayed for Apo D by a monoclonal anti-human Apo D antibody in Western blot. A mock precipitation (Lane 2) was conducted by substituting the anti-Ob-R antibody with normal goat IgG in the precipitation step to reveal proteins that were precipitated nonspecifically. various tissues and was used to synthesize cDNA, which was then used as template for qua titative PCR. The length of the PCR product is 570 bp for Apo D, 909 bp for Ob-Rb, and 105 bp for Ob-Ra. A 540-bp fragment of G3PDH (glyceraldehyde-3 phosphate dehydrogenase) was amplified simultaneously and used as an internal control. These PCR products were resolved in a 5% polyacrylamide gel, transferred onto a nylon membrane, and hybridized with their specific 32 P-labeled PCR primers. 
